<?xml version="1.0" encoding="UTF-8"?>
<svg height="813.2" width="537.0" xmlns="http://www.w3.org/2000/svg">
 <g>
  <text svgx:width="0.61,0.61,0.67,0.56,0.33,0.25,0.44,0.5,0.5,0.39,0.5,0.5,0.28,0.25,0.5,0.5,0.5,0.5,0.33,0.5,0.5,0.33,0.5,0.5,0.5,0.5,0.33,0.5,0.5,0.5,0.5,0.25,0.5,0.25,0.33,0.5,0.5,0.67,0.25,0.5,0.5,0.5,0.5,0.33,0.5,0.5,0.5,0.5,0.25" y="44.8" x="315.6,321.4,327.2,333.5,338.8,342.0,344.4,348.6,353.3,358.1,361.7,366.5,371.2,373.9,376.3,381.1,385.8,390.6,395.3,398.5,403.2,408.0,411.1,415.9,420.6,425.3,430.1,433.3,438.1,442.8,447.6,452.3,454.7,459.5,461.9,465.0,469.8,474.5,480.8,483.2,488.0,492.8,497.5,502.3,505.4,510.2,514.9,519.7,524.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">EXCLI Journal 2017;16:1103-1113 – ISSN 1611-2156 </text>
  <text svgx:width="0.61,0.44,0.44,0.44,0.28,0.44,0.44,0.5" y="55.7" x="217.3,223.1,227.3,231.5,235.7,238.4,242.6,246.8" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Received</text>
  <text svgx:width="0.28" y="55.7" x="251.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">:</text>
  <text svgx:width="0.25,0.44,0.5,0.5,0.44,0.25,0.5,0.5,0.25,0.25,0.5,0.5,0.5,0.5,0.25,0.25,0.5,0.44,0.44,0.44,0.5,0.28,0.44,0.5" y="55.7" x="254.2,256.6,260.8,265.5,270.3,274.5,276.9,281.7,286.4,288.8,291.2,295.9,300.7,305.4,310.2,312.6,315.0,319.7,323.9,328.1,332.4,337.1,339.8,344.0" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx"> June 26, 2017, accepted</text>
  <text svgx:width="0.28" y="55.7" x="348.6" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">:</text>
  <text svgx:width="0.25,0.61,0.5,0.5,0.5,0.39,0.28,0.25,0.5,0.5,0.25,0.25,0.5,0.5,0.5,0.5,0.25,0.25,0.5,0.5,0.5,0.28,0.28,0.39,0.5,0.44,0.5" y="55.7" x="351.2,353.6,359.4,364.2,368.9,373.7,377.4,380.0,382.4,387.2,391.9,394.3,396.7,401.4,406.2,410.9,415.7,418.0,420.4,425.2,429.9,434.7,437.3,440.0,443.6,448.4,452.7" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx"> August 17, 2017, published</text>
  <text svgx:width="0.28" y="55.7" x="457.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">:</text>
  <text svgx:width="0.25,0.61,0.5,0.5,0.5,0.39,0.28,0.25,0.5,0.5,0.25,0.25,0.5,0.5,0.5,0.5,0.25" y="55.7" x="460.0,462.4,468.2,473.0,477.7,482.5,486.1,488.8,491.2,495.9,500.7,503.1,505.5,510.2,514.9,519.7,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx"> August 29, 2017 </text>
  <text svgx:width="0.5,0.5,0.5,0.5,0.25" y="803.2" x="285.7,291.7,297.7,303.7,309.7" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">1112 </text>
  <text svgx:width="0.72,0.5,0.78,0.44,0.33,0.25,0.55,0.72,0.39,0.25,0.25,0.55,0.72,0.44,0.5,0.5,0.25,0.55,0.39,0.67,0.25,0.25,0.55,0.67,0.5,0.5,0.25,0.55,0.56,0.72,0.25,0.25,0.55,0.67,0.5,0.44,0.5,0.5,0.25,0.55,0.56,0.61,0.25,0.25,0.55,0.94,0.44,0.5,0.5,0.25,0.55,0.56,0.72,0.25,0.25" y="94.3" x="70.9,78.2,83.2,90.9,95.3,98.7,101.2,102.1,109.3,113.2,115.8,118.3,119.1,126.4,130.7,135.8,140.8,143.3,144.1,148.1,154.8,157.3,159.8,160.7,167.4,172.4,177.4,179.9,180.8,186.4,193.6,196.1,198.6,199.6,206.2,211.2,215.7,220.7,225.7,228.2,229.1,234.7,240.8,243.3,245.8,246.6,256.1,260.6,265.6,270.6,273.1,274.0,279.6,286.8,289.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Kumar KJ, Yang JC, Chu FH, Chang ST, Wang SY. </text>
  <text svgx:width="0.61,0.5,0.44,0.28,0.5,0.5,0.5,0.44,0.25,0.25,0.55,0.44,0.25,0.55,0.5,0.5,0.5,0.44,0.28,0.25,0.55,0.78,0.44,0.28,0.44,0.5,0.28,0.5,0.25,0.55,0.28,0.5,0.5,0.28,0.5,0.28,0.28,0.5,0.33,0.25,0.55,0.33,0.33,0.5,0.78,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.33,0.33,0.5,0.28,0.28,0.25,0.55,0.5,0.33,0.25" y="105.7" x="70.9,77.1,82.1,86.6,89.3,94.3,99.3,104.3,108.8,111.2,113.8,114.7,119.1,121.6,122.6,127.6,132.6,137.6,142.1,144.8,147.3,148.3,156.0,160.4,163.2,167.6,172.6,175.4,180.4,182.9,183.9,186.7,191.7,196.7,199.4,204.5,207.2,210.0,215.0,218.3,220.8,221.7,225.1,228.4,233.4,241.1,243.6,244.6,247.3,252.4,256.9,259.4,260.3,263.6,266.9,272.0,274.7,277.5,280.0,280.9,285.9,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Lucidone, a novel melanin inhibitor from the fruit of </text>
  <text svgx:width="0.61,0.28,0.5,0.5,0.44,0.33,0.44,0.25,0.44,0.33,0.5,0.28,0.5,0.33,0.5,0.44,0.44,0.33,0.5,0.44,0.25,0.89,0.44,0.5,0.28,0.5,0.5,0.25,0.25,0.56,0.5,0.5,0.28,0.5,0.28,0.5,0.44,0.33,0.25,0.67,0.44,0.39,0.25" y="117.2" x="70.9,77.1,79.8,84.8,89.9,94.3,97.6,102.1,104.3,108.8,112.1,117.1,119.8,124.8,128.1,133.1,137.6,142.1,145.4,150.4,154.9,157.1,166.0,170.4,175.4,178.1,183.1,188.1,190.6,192.8,198.4,203.4,208.4,211.2,216.2,218.9,223.9,228.4,231.8,234.0,240.6,245.1,248.9" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Lindera erythrocarpa Makino. Phytother Res.</text>
  <text svgx:width="0.5,0.5,0.5,0.5,0.28,0.5,0.5,0.28" y="117.2" x="253.6,258.6,263.6,268.6,273.7,276.4,281.4,286.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2010;24:</text>
  <text svgx:width="0.5,0.5,0.5,0.5,0.33,0.5,0.5,0.25,0.25" y="128.7" x="70.9,76.0,80.9,85.9,91.0,94.3,99.2,104.3,106.7" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">1158-65. </text>
  <text svgx:width="0.61,0.44,0.5,0.5,0.25,0.55,0.72,0.25,0.25,0.55,0.67,0.5,0.44,0.5,0.5,0.44,0.5,0.44,0.33,0.25,0.55,0.72,0.25,0.25,0.55,0.72,0.25,0.55,0.33,0.44,0.5,0.28,0.44,0.72,0.25,0.55,0.5,0.5,0.25,0.55,0.33,0.44,0.44,0.44,0.5,0.28,0.25,0.55,0.33,0.44,0.39,0.44,0.44,0.33,0.44,0.5,0.25" y="150.2" x="70.9,77.0,81.4,86.4,91.5,94.0,95.5,102.8,105.3,107.8,109.4,116.1,121.1,125.5,130.5,135.5,140.0,145.0,149.4,152.7,155.2,156.9,164.1,166.5,169.0,170.6,177.8,180.3,182.0,185.3,189.7,194.7,197.5,201.9,209.1,211.6,213.3,218.3,223.2,225.8,227.4,230.7,235.2,239.6,244.0,249.0,251.8,254.3,255.9,259.3,263.7,267.6,272.0,276.4,279.8,284.2,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Lang G, Buchbauer G. A review on recent research </text>
  <text svgx:width="0.33,0.44,0.39,0.5,0.28,0.28,0.39,0.25,0.33,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.33,0.25,0.5,0.5,0.25,0.44,0.39,0.39,0.44,0.5,0.28,0.28,0.44,0.28,0.25,0.5,0.28,0.28,0.39,0.25,0.44,0.39,0.25,0.44,0.5,0.28,0.28,0.78,0.28,0.44,0.33,0.5,0.5,0.28,0.44,0.28,0.39,0.25" y="161.7" x="70.9,74.2,78.7,82.6,87.6,90.4,93.1,97.0,99.7,103.0,108.0,113.0,118.0,123.0,128.0,133.0,138.0,143.0,148.0,151.4,154.1,159.1,164.1,166.8,171.2,175.1,179.0,183.4,188.4,191.2,194.0,198.4,201.2,203.9,208.9,211.7,214.4,218.3,221.0,225.4,229.3,232.0,236.5,241.5,244.3,247.0,254.8,257.5,262.0,265.3,270.3,275.4,278.1,282.5,285.3,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">results (2008–2010) on essential oils as antimicrobials </text>
  <text svgx:width="0.44,0.5,0.5,0.25,0.44,0.5,0.28,0.28,0.33,0.5,0.5,0.5,0.44,0.28,0.39,0.25,0.25,0.72,0.25,0.33,0.44,0.5,0.28,0.44,0.72,0.25,0.25,0.56,0.28,0.44,0.5,0.25,0.56,0.33,0.44,0.5,0.33,0.44,0.5,0.44,0.44,0.25,0.39,0.25" y="173.2" x="70.9,75.4,80.4,85.4,88.3,92.7,97.7,100.5,103.3,106.6,111.7,116.7,121.7,126.1,128.9,132.8,135.3,138.2,145.4,148.4,151.7,156.1,161.1,163.9,168.3,175.5,178.0,180.9,186.5,189.3,193.7,198.7,201.6,207.2,210.5,214.9,219.9,223.2,227.7,232.7,237.1,241.5,244.4,248.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">and antifungals. A review. Flav Fragrance J.</text>
  <text svgx:width="0.5,0.5,0.5,0.5,0.28,0.5,0.5,0.28,0.25" y="173.2" x="253.7,258.7,263.7,268.7,273.7,276.5,281.5,286.5,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2012;27: </text>
  <text svgx:width="0.5,0.5,0.33,0.5,0.5,0.25,0.25" y="184.7" x="70.9,76.0,80.9,84.2,89.3,94.3,96.7" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">13-39. </text>
  <text svgx:width="0.61,0.44,0.44,0.25,0.56,0.39,0.25,0.25,0.67,0.44,0.28,0.25,0.56,0.72,0.25,0.25,0.61,0.44,0.44,0.25,0.72,0.56,0.25,0.25,0.72,0.44,0.78,0.5,0.5,0.5,0.5,0.5,0.25,0.56,0.25,0.25,0.72,0.44,0.25,0.72,0.39,0.25,0.25,0.72,0.44,0.25,0.72,0.56,0.25,0.25" y="206.2" x="70.9,77.1,81.5,86.0,88.4,94.0,97.9,100.4,102.9,109.6,114.0,116.8,119.3,124.9,132.1,134.6,137.0,143.2,147.6,152.1,154.5,161.8,167.3,169.8,172.3,179.5,184.0,191.7,196.7,201.7,206.7,211.7,216.7,219.1,224.7,227.2,229.7,236.9,241.4,243.8,251.0,254.9,257.4,259.8,267.1,271.5,273.9,281.2,286.8,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Lee SJ, Bai SK, Lee KS, Namkoong S, Na HJ, Ha KS, </text>
  <text svgx:width="0.44,0.28,0.25,0.44,0.28,0.25,0.25,0.72,0.39,0.28,0.44,0.5,0.44,0.5,0.28,0.5,0.28,0.5,0.25,0.28,0.5,0.5,0.28,0.5,0.28,0.28,0.39,0.25,0.5,0.28,0.28,0.33,0.28,0.44,0.25,0.5,0.5,0.28,0.5,0.44,0.25,0.5,0.33,0.5,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.44,0.5,0.5,0.25" y="217.7" x="70.9,75.4,78.2,81.3,85.7,88.5,91.0,94.2,101.4,105.3,108.1,112.5,117.6,122.0,127.1,129.8,134.8,137.6,142.6,145.7,148.5,153.4,158.5,161.2,166.3,169.0,171.8,175.7,178.8,183.8,186.6,189.3,192.7,195.4,199.9,203.0,208.0,213.1,215.8,220.8,225.3,228.4,233.4,236.7,241.7,246.7,251.7,256.2,258.9,261.7,266.7,271.8,274.9,279.3,284.2,289.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">et al. Astaxanthin inhibits nitric oxide production and </text>
  <text svgx:width="0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25,0.55,0.5,0.44,0.5,0.44,0.25,0.55,0.44,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.39,0.5,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25" y="229.2" x="70.9,73.7,78.7,82.1,84.8,89.3,97.0,104.8,109.2,112.0,117.0,120.4,125.4,127.9,136.6,141.7,146.0,151.1,155.4,158.0,166.7,171.2,176.2,181.1,184.4,188.9,192.8,196.7,199.5,204.5,209.5,212.0,220.7,225.7,230.7,233.2,242.0,245.8,250.9,255.9,260.8,264.2,268.7,272.6,276.5,279.3,284.2,289.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">inflammatory gene expression by suppressing </text>
  <text svgx:width="0.33,0.33,0.5,0.44,0.5,0.5,0.44,0.33,0.67,0.25,0.55,0.5,0.28,0.5,0.44,0.39,0.44,0.33,0.5,0.44,0.5,0.44,0.5,0.5,0.44,0.5,0.28,0.25,0.55,0.72,0.56,0.33,0.5,0.44,0.5,0.5,0.44,0.67,0.25,0.55,0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.25" y="240.7" x="70.9,74.3,77.6,82.6,87.1,92.0,97.1,101.5,104.8,111.5,114.0,117.8,122.9,125.6,130.6,135.1,139.0,143.4,146.8,151.8,156.2,161.2,165.6,170.6,175.7,180.1,185.1,187.8,190.3,194.2,201.4,207.0,210.3,215.3,219.8,224.8,229.8,234.2,240.8,243.4,247.2,251.7,256.1,258.9,261.7,266.7,271.2,273.9,276.7,281.7,286.7,289.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">I(kappa)B kinase-dependent NF-kappaB activation. </text>
  <text svgx:width="0.89,0.5,0.28,0.25,0.67,0.44,0.28,0.28,0.39,0.25" y="252.2" x="70.9,79.8,84.8,87.6,90.1,96.8,101.2,104.0,106.8,110.6" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Mol Cells.</text>
  <text svgx:width="0.5,0.5,0.5,0.5,0.28,0.5,0.5,0.28,0.5,0.5,0.33,0.5,0.5,0.5,0.25,0.25" y="252.2" x="115.7,120.7,125.6,130.6,135.7,138.4,143.4,148.4,151.2,156.2,161.2,164.5,169.5,174.5,179.5,182.0" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2003;16:97-105. </text>
  <text svgx:width="0.61,0.28,0.5,0.39,0.5,0.5,0.25,0.56,0.61,0.25,0.25,0.61,0.5,0.44,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.5,0.5,0.28,0.44,0.5,0.28,0.28,0.44,0.28,0.25,0.5,0.33,0.25,0.44,0.5,0.44,0.28,0.5,0.5,0.5,0.5,0.5,0.44,0.5,0.44,0.39,0.44,0.33,0.5,0.33" y="273.7" x="70.9,77.0,79.8,84.8,88.7,93.7,98.7,100.7,106.3,112.4,114.9,117.0,123.1,128.1,132.5,134.6,139.1,141.9,144.6,149.6,152.4,156.8,161.3,164.1,166.2,171.2,176.2,179.0,183.4,188.4,191.2,194.0,198.4,201.2,203.3,208.3,211.6,213.7,218.2,223.2,227.6,230.4,235.4,240.4,245.4,250.4,255.4,259.8,264.8,269.2,273.1,277.5,280.9,285.9" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Lipsky PE. The clinical potential of cyclooxygenase-2-</text>
  <text svgx:width="0.39,0.5,0.44,0.44,0.28,0.33,0.28,0.44,0.25,0.28,0.5,0.5,0.28,0.5,0.28,0.28,0.5,0.33,0.39,0.25,0.25,0.72,0.78,0.25,0.39,0.25,0.89,0.44,0.5,0.25" y="285.2" x="70.9,74.8,79.8,84.3,88.7,91.5,94.9,97.7,102.1,104.6,107.4,112.4,117.5,120.2,125.2,128.0,130.8,135.8,139.1,143.0,145.5,147.9,155.2,162.8,165.4,169.3,171.8,180.7,185.2,190.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">specific inhibitors. Am J Med.</text>
  <text svgx:width="0.5,0.5,0.5,0.5,0.28,0.5,0.5,0.5,0.28,0.5,0.5,0.56,0.33,0.5,0.56,0.25,0.25" y="285.2" x="195.1,200.1,205.1,210.1,215.2,217.9,222.9,227.9,232.9,235.7,240.7,245.7,251.2,254.6,259.6,265.1,267.6" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">1999;106:51S-7S. </text>
  <text svgx:width="0.61,0.28,0.5,0.25,0.72,0.25,0.25,0.56,0.5,0.44,0.5,0.5,0.44,0.33,0.5,0.25,0.61,0.72,0.25,0.25,0.72,0.44,0.28,0.28,0.5,0.25,0.61,0.72,0.25,0.25,0.89,0.72,0.56,0.72,0.25,0.5,0.5,0.5,0.39,0.5,0.5,0.44,0.28,0.44,0.39,0.44,0.39,0.33" y="306.7" x="70.9,77.0,79.8,84.8,87.4,94.6,97.1,99.7,105.2,110.3,114.7,119.7,124.8,129.2,132.5,137.6,140.1,146.2,153.4,155.9,158.5,165.8,170.2,173.0,175.7,180.7,183.3,189.4,196.6,199.1,201.7,210.5,217.8,223.3,230.6,233.2,238.2,243.1,248.1,252.0,257.0,262.0,266.4,269.2,273.6,277.5,281.9,285.8" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Liu Y, Shepherd EG, Nelin LD. MAPK phosphatases-</text>
  <text svgx:width="0.33,0.33,0.44,0.5,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.28,0.78,0.78,0.5,0.5,0.44,0.25,0.55,0.33,0.44,0.39,0.5,0.5,0.5,0.39,0.44,0.25,0.25,0.55,0.72,0.44,0.28,0.25,0.55,0.67,0.44,0.5,0.25,0.55,0.33,0.78,0.78,0.5,0.5,0.5,0.28,0.25" y="318.2" x="70.9,74.3,77.6,82.0,87.1,92.1,94.8,99.3,102.1,104.8,109.8,114.9,117.4,118.6,121.3,126.3,130.7,133.2,134.4,137.2,145.0,152.6,157.7,162.7,167.2,169.7,170.9,174.3,178.7,182.6,187.6,192.6,197.6,201.5,205.9,208.5,211.0,212.1,219.4,223.8,226.6,229.1,230.3,237.0,241.4,246.3,248.8,250.1,253.4,261.2,268.8,273.9,278.9,283.9,286.7" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">-regulating the immune response. Nat Rev Immunol.</text>
  <text svgx:width="0.5,0.5,0.5,0.5,0.28,0.5,0.28,0.5,0.5,0.5,0.33,0.5,0.5,0.25,0.25" y="329.7" x="70.9,76.0,80.9,85.9,91.0,93.7,98.8,101.5,106.5,111.5,116.5,119.8,124.8,129.8,132.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2007;7:202-12. </text>
  <text svgx:width="0.61,0.28,0.5,0.5,0.5,0.25,0.55,0.61,0.25,0.25,0.55,0.61,0.5,0.5,0.5,0.5,0.44,0.33,0.5,0.25,0.55,0.56,0.25,0.25,0.55,0.72,0.44,0.33,0.39,0.44,0.5,0.5,0.28,0.25,0.55,0.89,0.25,0.25,0.55,0.39,0.5,0.5,0.44,0.5,0.39,0.39,0.5,0.5,0.25,0.55,0.67,0.25,0.25" y="351.2" x="70.9,77.1,79.8,84.9,89.8,94.9,97.4,100.7,106.8,109.3,111.8,115.2,121.3,126.2,131.2,136.3,141.3,145.7,149.0,154.0,156.5,159.9,165.5,167.9,170.4,173.8,181.1,185.4,188.7,192.6,197.1,202.1,207.1,209.9,212.4,215.8,224.6,227.2,229.7,233.0,236.9,241.9,246.9,251.3,256.4,260.3,264.1,269.2,274.1,276.7,280.0,286.7,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Ljung T, Lundberg S, Varsanyi M, Johansson C, </text>
  <text svgx:width="0.56,0.44,0.5,0.78,0.28,0.5,0.28,0.25,0.55,0.56,0.61,0.25,0.25,0.55,0.72,0.44,0.33,0.5,0.28,0.33,0.25,0.55,0.89,0.25,0.25,0.55,0.44,0.28,0.25,0.55,0.44,0.28,0.25,0.25,0.55,0.67,0.44,0.44,0.28,0.44,0.28,0.25,0.55,0.5,0.28,0.28,0.33,0.28,0.44,0.25,0.55,0.5,0.5,0.28,0.5,0.44,0.25,0.55,0.44,0.39,0.25" y="362.7" x="70.9,76.5,80.9,86.0,93.6,96.4,101.4,104.2,106.7,108.6,114.2,120.3,122.8,125.3,127.1,134.3,138.7,142.1,147.1,149.9,153.2,155.7,157.6,166.5,169.0,171.5,173.3,177.8,180.5,183.0,184.8,189.2,192.0,194.5,197.0,198.9,205.5,210.0,214.4,217.2,221.6,224.4,226.9,228.8,233.8,236.6,239.3,242.7,245.4,249.8,252.3,254.2,259.2,264.2,267.0,272.0,276.5,279.0,280.9,285.3,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Schmidt PT, Herulf M, et al. Rectal nitric oxide as </text>
  <text svgx:width="0.5,0.28,0.5,0.78,0.44,0.33,0.5,0.44,0.33,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25,0.55,0.5,0.5,0.72,0.44,0.28,0.25" y="374.2" x="70.9,75.9,78.7,83.7,91.4,95.9,99.2,104.2,108.7,112.0,114.5,117.4,120.2,125.1,127.7,130.5,133.2,138.3,142.8,145.3,148.2,150.9,154.3,158.7,163.2,166.0,173.6,178.1,183.1,185.9,188.4,191.3,196.3,199.6,202.1,205.0,207.7,212.7,216.1,218.8,223.3,231.0,238.8,243.2,246.0,251.1,254.4,259.4,261.9,264.8,269.8,274.8,282.0,286.5,289.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">biomarker in the treatment of inflammatory bowel </text>
  <text svgx:width="0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.28,0.25,0.55,0.33,0.44,0.39,0.5,0.5,0.5,0.5,0.44,0.33,0.39,0.25,0.55,0.5,0.44,0.33,0.39,0.5,0.39,0.25,0.55,0.5,0.5,0.5,0.33,0.44,0.39,0.5,0.5,0.5,0.5,0.44,0.33,0.39,0.25,0.25,0.55,0.94,0.5,0.33,0.28,0.5,0.25,0.55,0.39,0.25" y="385.7" x="70.9,75.9,78.7,82.6,87.1,91.6,95.5,99.9,102.7,105.2,108.2,111.6,116.0,119.9,124.8,129.8,134.9,139.9,144.3,147.6,151.5,154.0,157.0,162.0,166.4,169.8,173.7,178.7,182.5,185.1,188.0,193.0,198.0,203.0,206.4,210.8,214.7,219.7,224.7,229.7,234.8,239.1,242.5,246.4,248.9,251.4,254.3,263.8,268.8,272.2,274.9,279.9,282.4,285.4,289.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">disease: responders versus nonresponders. World J </text>
  <text svgx:width="0.72,0.44,0.39,0.28,0.33,0.5,0.44,0.5,0.28,0.44,0.33,0.5,0.28,0.25" y="397.2" x="70.9,78.1,82.6,86.5,89.2,92.6,97.6,102.0,107.1,109.8,114.3,117.6,122.6,125.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Gastroenterol.</text>
  <text svgx:width="0.5,0.5,0.5,0.5,0.28,0.5,0.5,0.28,0.5,0.5,0.5,0.5,0.33,0.5,0.5,0.25,0.25" y="397.2" x="130.3,135.4,140.3,145.3,150.4,153.1,158.1,163.1,165.9,170.9,175.9,180.9,185.9,189.2,194.2,199.2,201.7" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2006;12:3386-92. </text>
  <text svgx:width="0.89,0.44,0.5,0.44,0.33,0.5,0.5,0.25,0.55,0.56,0.56,0.25,0.25,0.55,0.72,0.56,0.33,0.5,0.44,0.5,0.5,0.44,0.67,0.25,0.55,0.44,0.39,0.25,0.55,0.44,0.25,0.55,0.28,0.5,0.44,0.33,0.44,0.5,0.44,0.5,0.28,0.28,0.44,0.25,0.55,0.28,0.44,0.33,0.5,0.44,0.28,0.25,0.55,0.28,0.5,0.25" y="418.7" x="70.9,79.8,84.2,89.3,93.7,97.0,102.0,107.0,109.5,111.9,117.5,123.0,125.5,128.0,130.3,137.6,143.2,146.5,151.5,155.9,161.0,166.0,170.4,177.0,179.5,181.9,186.4,190.2,192.7,195.2,199.6,202.1,204.5,207.2,212.3,216.7,220.0,224.4,229.5,233.9,238.9,241.7,244.4,248.9,251.4,253.8,256.5,261.0,264.3,269.3,273.7,276.5,279.0,281.4,284.2,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Makarov SS. NF-kappaB as a therapeutic target in </text>
  <text svgx:width="0.44,0.5,0.33,0.5,0.5,0.28,0.44,0.25,0.55,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.28,0.5,0.5,0.28,0.25,0.55,0.33,0.44,0.44,0.44,0.5,0.28,0.25,0.55,0.44,0.5,0.5,0.44,0.5,0.44,0.44,0.39,0.25,0.25,0.55,0.89,0.5,0.28,0.25,0.55,0.89,0.44,0.5,0.25" y="430.2" x="70.9,75.4,80.4,83.7,88.7,93.7,96.5,100.9,103.4,107.5,110.3,115.3,118.7,121.5,125.8,133.6,141.3,145.8,148.6,151.3,156.4,161.4,164.2,166.7,170.8,174.1,178.6,183.0,187.4,192.4,195.2,197.7,201.8,206.2,211.2,216.3,220.7,225.7,230.2,234.6,238.5,240.9,243.4,247.5,256.4,261.5,264.2,266.7,270.8,279.7,284.1,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">chronic inflammation: recent advances. Mol Med </text>
  <text svgx:width="0.61,0.5,0.5,0.44,0.5,0.25" y="441.7" x="70.9,77.0,82.0,87.0,91.5,96.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Today.</text>
  <text svgx:width="0.5,0.5,0.5,0.5,0.28,0.5,0.28,0.5,0.5,0.5,0.33,0.5,0.25,0.25" y="441.7" x="101.5,106.5,111.5,116.5,121.5,124.3,129.3,132.0,137.0,142.0,147.0,150.4,155.3,157.8" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2000;6:441-8. </text>
  <text svgx:width="0.89,0.44,0.67,0.44,0.5,0.5,0.25,0.56,0.89,0.25,0.25,0.89,0.44,0.39,0.28,0.33,0.5,0.5,0.44,0.33,0.5,0.28,0.25,0.67,0.25,0.25,0.5,0.44,0.25,0.61,0.44,0.5,0.33,0.44,0.5,0.28,0.28,0.28,0.39,0.25,0.72,0.25,0.25,0.67,0.44,0.28,0.28,0.5,0.33,0.28,0.25" y="463.2" x="70.9,79.8,84.3,90.9,95.4,100.4,105.4,108.4,114.0,122.9,125.4,128.4,137.3,141.7,145.6,148.4,151.7,156.7,161.7,166.2,169.5,174.5,177.3,180.4,187.0,189.5,192.6,197.6,202.1,205.1,211.2,215.7,220.7,224.0,228.5,233.5,236.3,239.0,241.8,245.7,248.7,255.9,258.4,261.5,268.1,272.6,275.3,278.1,283.1,286.4,289.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">McCann SM, Mastronardi C, de Laurentiis A, Rettori </text>
  <text svgx:width="0.72,0.25,0.25,0.61,0.5,0.44,0.25,0.5,0.28,0.28,0.33,0.28,0.44,0.25,0.5,0.5,0.28,0.5,0.44,0.25,0.28,0.5,0.44,0.5,0.33,0.5,0.25,0.5,0.33,0.25,0.44,0.5,0.28,0.5,0.5,0.25,0.33,0.44,0.5,0.28,0.39,0.28,0.28,0.44,0.5,0.25,0.25,0.72,0.5,0.5,0.25,0.72,0.25,0.72,0.25" y="474.7" x="70.9,78.1,80.6,83.1,89.2,94.2,98.7,101.2,106.2,109.0,111.8,115.1,117.9,122.3,124.8,129.8,134.8,137.6,142.6,147.0,149.6,152.3,157.3,161.7,166.8,170.1,175.1,177.6,182.6,185.9,188.3,192.8,197.8,200.6,205.6,210.6,213.1,216.4,220.8,225.9,228.6,232.5,235.3,238.1,242.5,247.5,250.0,252.5,259.7,264.7,269.8,272.2,279.4,281.9,289.1" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">V. The nitric oxide theory of aging revisited. Ann N Y </text>
  <text svgx:width="0.72,0.44,0.44,0.5,0.25,0.56,0.44,0.28,0.25" y="486.2" x="70.9,78.1,82.6,87.0,92.0,94.6,100.1,104.6,107.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Acad Sci.</text>
  <text svgx:width="0.5,0.5,0.5,0.5,0.28,0.5,0.5,0.5,0.5,0.28,0.5,0.5,0.33,0.5,0.5,0.25,0.25" y="486.2" x="112.3,117.3,122.3,127.3,132.3,135.1,140.1,145.1,150.1,155.2,157.9,162.9,167.9,171.2,176.2,181.2,183.7" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2005;1057:64-84. </text>
  <text svgx:width="0.72,0.44,0.5,0.44,0.5,0.5,0.25,0.55,0.72,0.25,0.25,0.55,0.56,0.5,0.28,0.5,0.5,0.5,0.25,0.55,0.89,0.25,0.25,0.55,0.56,0.44,0.5,0.5,0.5,0.25,0.55,0.56,0.25,0.25,0.55,0.72,0.28,0.39,0.5,0.28,0.5,0.44,0.5,0.44,0.25,0.55,0.56,0.25,0.25,0.55,0.89,0.28,0.5,0.44,0.33,0.44,0.25" y="507.7" x="70.9,78.2,82.6,87.7,92.0,97.0,102.1,104.6,105.4,112.7,115.1,117.6,118.6,124.1,129.1,131.9,136.9,141.9,147.0,149.5,150.4,159.2,161.7,164.2,165.1,170.7,175.1,180.1,185.1,190.1,192.6,193.5,199.1,201.5,204.0,205.0,212.2,215.0,218.8,223.9,226.6,231.7,236.1,241.1,245.6,248.1,248.9,254.5,256.9,259.4,260.3,269.2,272.0,277.0,281.4,284.8,289.1" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Nakano H, Shindo M, Sakon S, Nishinaka S, Mihara </text>
  <text svgx:width="0.89,0.25,0.25,0.72,0.44,0.5,0.28,0.28,0.44,0.25,0.72,0.25,0.25,0.44,0.28,0.25,0.44,0.28,0.25,0.25,0.72,0.28,0.33,0.33,0.44,0.33,0.44,0.5,0.28,0.28,0.44,0.28,0.25,0.33,0.44,0.5,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.33,0.5,0.44,0.5,0.5,0.44,0.67,0.25" y="519.2" x="70.9,79.8,82.3,85.4,92.6,97.0,102.0,104.8,107.6,112.1,115.1,122.3,124.8,127.8,132.2,135.0,138.0,142.5,145.3,147.8,150.8,158.1,160.9,164.2,167.5,171.9,175.3,179.6,184.6,187.4,190.2,194.6,197.4,200.4,203.7,208.2,213.2,218.2,221.0,225.4,228.2,231.0,236.0,241.0,244.0,249.0,252.3,255.3,258.6,263.7,268.1,273.1,278.1,282.6,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">M, Yagita H, et al. Differential regulation of IkappaB </text>
  <text svgx:width="0.5,0.28,0.5,0.44,0.39,0.44,0.25,0.55,0.44,0.28,0.5,0.5,0.44,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.44,0.28,0.44,0.25,0.55,0.5,0.5,0.25,0.55,0.28,0.72,0.5,0.25,0.55,0.5,0.5,0.39,0.28,0.33,0.44,0.44,0.78,0.25,0.55,0.5,0.28,0.5,0.44,0.39,0.44,0.39,0.25,0.25,0.55,0.72,0.56,0.33" y="530.7" x="70.9,75.9,78.7,83.7,88.2,92.1,96.6,99.1,100.3,104.8,107.5,112.5,117.6,122.0,124.5,125.8,130.2,135.2,140.2,142.7,144.0,149.0,153.4,156.2,160.6,163.1,164.4,169.4,174.4,176.9,178.2,181.0,188.2,193.2,195.7,197.0,202.0,207.0,210.9,213.7,217.0,221.5,225.9,233.6,236.1,237.4,242.4,245.2,250.2,254.7,258.6,263.0,267.0,269.5,272.0,273.2,280.4,286.0" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">kinase alpha and beta by two upstream kinases, NF-</text>
  <text svgx:width="0.5,0.44,0.5,0.5,0.44,0.67,0.33,0.28,0.5,0.5,0.5,0.44,0.28,0.5,0.5,0.25,0.5,0.28,0.5,0.44,0.39,0.44,0.25,0.44,0.5,0.5,0.25,0.78,0.28,0.28,0.5,0.5,0.44,0.5,0.33,0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.44,0.5,0.25,0.5,0.33,0.5,0.28,0.44,0.28,0.5,0.25" y="542.2" x="70.9,75.9,80.4,85.4,90.4,94.9,101.6,104.9,107.6,112.6,117.6,122.6,127.1,129.8,134.8,139.9,142.0,147.0,149.8,154.8,159.2,163.1,167.6,169.8,174.3,179.2,184.3,186.4,194.2,196.9,199.7,204.7,209.7,214.2,219.2,222.6,227.1,231.5,234.3,237.0,242.1,246.5,249.2,253.7,258.7,260.9,265.9,269.3,274.3,277.1,281.5,284.3,289.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">kappaB-inducing kinase and mitogen-activated protein </text>
  <text svgx:width="0.5,0.28,0.5,0.44,0.39,0.44,0.28,0.61,0.67,0.72,0.25,0.5,0.28,0.5,0.44,0.39,0.44,0.25,0.5,0.28,0.5,0.44,0.39,0.44,0.33,0.5,0.25,0.25,0.56,0.33,0.5,0.44,0.25,0.72,0.44,0.28,0.28,0.25,0.72,0.44,0.44,0.5,0.25,0.56,0.44,0.28,0.25,0.72,0.25,0.56,0.25" y="553.7" x="70.9,75.9,78.7,83.7,88.2,92.1,96.6,99.3,105.4,112.0,119.3,122.5,127.5,130.3,135.3,139.8,143.7,148.1,151.3,156.3,159.1,164.1,168.6,172.5,176.9,180.2,185.2,187.7,190.9,196.5,199.8,204.8,209.3,212.5,219.8,224.2,227.0,229.7,232.9,240.2,244.6,249.0,254.0,257.3,262.9,267.3,270.1,273.3,280.5,283.8,289.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">kinase/ERK kinase kinase-1. Proc Natl Acad Sci U S </text>
  <text svgx:width="0.72,0.25" y="565.2" x="70.9,78.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">A.</text>
  <text svgx:width="0.5,0.5,0.5,0.5,0.28,0.5,0.5,0.28,0.5,0.5,0.5,0.5,0.33,0.5,0.5,0.25,0.25" y="565.2" x="83.2,88.1,93.2,98.2,103.2,106.0,110.9,116.0,118.7,123.7,128.7,133.7,138.7,142.0,147.0,152.0,154.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">1998;95:3537-42. </text>
  <text svgx:width="0.72,0.5,0.25,0.72,0.33,0.89,0.25,0.25,0.67,0.5,0.5,0.28,0.25,0.56,0.33,0.72,0.25,0.25,0.61,0.44,0.44,0.25,0.39,0.89,0.25,0.25,0.61,0.44,0.44,0.25,0.56,0.33,0.72,0.25,0.25,0.72,0.28,0.78,0.25,0.72,0.33,0.72,0.25,0.25,0.72,0.44,0.5,0.25" y="586.7" x="70.9,78.2,83.1,85.9,93.1,96.5,105.3,107.9,110.6,117.2,122.2,127.3,130.0,132.7,138.3,141.6,148.9,151.4,154.1,160.2,164.7,169.1,171.9,175.8,184.7,187.2,189.9,196.0,200.5,205.0,207.7,213.3,216.6,223.8,226.3,229.1,236.3,239.1,246.8,249.5,256.8,260.1,267.3,269.9,272.6,279.8,284.2,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Oh H-M, Choi S-K, Lee JM, Lee S-K, Kim H-Y, Han </text>
  <text svgx:width="0.72,0.67,0.25,0.25,0.55,0.44,0.28,0.25,0.55,0.44,0.28,0.25,0.25,0.55,0.67,0.5,0.44,0.28,0.5,0.5,0.44,0.5,0.28,0.44,0.5,0.44,0.5,0.28,0.5,0.5,0.44,0.39,0.25,0.25,0.55,0.28,0.5,0.5,0.28,0.5,0.28,0.28,0.5,0.33,0.39,0.25,0.55,0.5,0.33,0.25,0.55,0.33,0.44,0.33,0.5,0.44,0.39,0.5,0.28,0.25" y="598.2" x="70.9,78.2,84.8,87.4,89.9,91.1,95.6,98.3,100.8,102.1,106.6,109.3,111.8,114.3,115.6,122.3,127.3,131.6,134.4,139.4,144.5,148.8,153.9,156.6,161.1,166.1,170.5,175.5,178.3,183.3,188.3,192.7,196.6,199.1,201.6,202.9,205.7,210.7,215.7,218.4,223.5,226.2,228.9,234.0,237.3,241.2,243.7,244.9,249.9,253.2,255.7,257.0,260.4,264.7,268.1,273.1,277.6,281.5,286.5,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">DC, et al. Cyclopentenediones, inhibitors of farnesyl </text>
  <text svgx:width="0.5,0.33,0.5,0.28,0.44,0.28,0.5,0.25,0.28,0.33,0.44,0.5,0.39,0.33,0.44,0.33,0.44,0.39,0.44,0.25,0.44,0.5,0.5,0.25,0.44,0.5,0.28,0.28,0.33,0.28,0.5,0.78,0.5,0.33,0.25,0.44,0.5,0.78,0.5,0.5,0.5,0.5,0.5,0.39,0.25,0.25,0.28,0.39,0.5,0.28,0.44,0.28,0.44,0.5,0.25" y="609.7" x="70.9,76.0,79.3,84.3,87.1,91.5,94.2,99.2,101.3,104.1,107.4,111.9,116.9,120.8,124.1,128.6,131.9,136.3,140.2,144.6,146.7,151.1,156.2,161.1,163.2,167.7,172.7,175.5,178.2,181.6,184.3,189.3,197.0,202.0,205.4,207.5,211.9,217.0,224.7,229.7,234.7,239.7,244.7,249.7,253.6,256.0,258.1,260.9,264.8,269.8,272.6,277.0,279.7,284.2,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">protein transferase and anti-tumor compounds, isolated </text>
  <text svgx:width="0.33,0.33,0.5,0.78,0.25,0.28,0.5,0.44,0.25,0.33,0.33,0.5,0.28,0.28,0.25,0.5,0.33,0.25,0.61,0.28,0.5,0.5,0.44,0.33,0.44,0.25,0.44,0.33,0.5,0.28,0.5,0.33,0.5,0.44,0.44,0.33,0.5,0.44,0.25,0.89,0.44,0.5,0.28,0.5,0.5,0.25,0.25,0.67,0.28,0.5,0.5,0.33,0.5,0.25" y="621.2" x="70.9,74.3,77.6,82.6,90.3,92.9,95.6,100.7,105.2,107.7,111.1,114.5,119.5,122.2,125.0,127.5,132.6,135.9,138.5,144.7,147.4,152.4,157.4,161.8,165.2,169.6,172.2,176.6,180.0,184.9,187.7,192.7,196.0,201.1,205.5,210.0,213.3,218.3,222.8,225.4,234.3,238.7,243.7,246.5,251.5,256.5,259.0,261.6,268.2,271.0,276.0,281.0,284.3,289.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">from the fruit of Lindera erythrocarpa Makino. Bioorg </text>
  <text svgx:width="0.89,0.44,0.5,0.25,0.67,0.5,0.44,0.78,0.25" y="632.7" x="70.9,79.8,84.2,89.3,91.8,98.5,103.5,107.9,115.6" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Med Chem.</text>
  <text svgx:width="0.5,0.5,0.5,0.5,0.28,0.5,0.5,0.28,0.5,0.5,0.5,0.5,0.33,0.5,0.25,0.25" y="632.7" x="120.7,125.6,130.6,135.7,140.7,143.4,148.4,153.5,156.2,161.2,166.2,171.2,176.2,179.5,184.6,187.0" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2005;13:6182-7. </text>
  <text svgx:width="0.56,0.28,0.5,0.5,0.44,0.28,0.33,0.5,0.25,0.55,0.67,0.72,0.25,0.25,0.55,0.56,0.28,0.28,0.5,0.44,0.25,0.55,0.72,0.56,0.25,0.25,0.55,0.56,0.5,0.5,0.44,0.44,0.25,0.55,0.72,0.61,0.25,0.25,0.55,0.56,0.28,0.5,0.5,0.44,0.28,0.33,0.44,0.5,0.5,0.25,0.55,0.39,0.72,0.25,0.25" y="654.2" x="70.9,76.5,79.3,84.3,89.3,93.8,96.5,99.8,104.9,107.4,109.8,116.4,123.7,126.2,128.7,131.1,136.7,139.5,142.2,147.3,151.7,154.2,156.7,164.0,169.5,172.0,174.5,177.0,182.6,187.5,192.5,197.0,201.4,203.9,206.4,213.7,219.8,222.3,224.8,227.3,232.9,235.6,240.6,245.6,250.1,252.8,256.2,260.6,265.6,270.6,273.1,275.6,279.4,286.7,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Pinheiro BG, Silva AS, Souza GE, Figueiredo JG, </text>
  <text svgx:width="0.67,0.5,0.5,0.5,0.44,0.25,0.55,0.56,0.72,0.25,0.25,0.55,0.61,0.44,0.5,0.28,0.5,0.5,0.25,0.55,0.56,0.25,0.25,0.55,0.44,0.28,0.25,0.55,0.44,0.28,0.25,0.25,0.55,0.67,0.5,0.44,0.78,0.28,0.44,0.44,0.28,0.25,0.55,0.44,0.5,0.78,0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.5,0.25,0.25" y="665.7" x="70.9,77.6,82.6,87.6,92.6,97.0,99.5,101.8,107.4,114.6,117.1,119.6,121.9,127.9,132.4,137.4,140.2,145.2,150.2,152.7,155.0,160.5,163.0,165.5,167.8,172.3,175.0,177.6,179.8,184.3,187.0,189.5,192.0,194.3,200.9,205.9,210.4,218.1,220.8,225.3,229.8,232.5,235.0,237.3,241.8,246.8,254.5,259.5,264.5,268.4,271.1,273.9,276.7,281.7,286.7,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Cunha FQ, Lahlou S, et al. Chemical composition, </text>
  <text svgx:width="0.44,0.5,0.28,0.28,0.5,0.5,0.44,0.28,0.44,0.44,0.5,0.28,0.28,0.5,0.44,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.44,0.5,0.28,0.28,0.33,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25,0.55,0.44,0.33,0.33,0.44,0.44,0.28,0.39,0.25,0.55,0.28,0.5,0.25" y="677.2" x="70.9,75.3,80.4,83.2,85.9,91.0,96.0,100.4,103.2,107.6,112.1,117.1,119.9,122.6,127.7,132.1,134.6,141.0,145.4,150.4,155.5,158.0,164.4,168.8,173.8,176.6,179.3,182.7,185.4,190.4,193.7,196.5,200.9,208.7,216.5,220.9,223.7,228.7,232.0,237.0,239.5,245.9,250.4,253.7,257.0,261.4,265.9,268.6,272.5,275.0,281.4,284.1,289.1" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">antinociceptive and anti-inflammatory effects in </text>
  <text svgx:width="0.33,0.5,0.5,0.44,0.5,0.28,0.39,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.44,0.39,0.39,0.44,0.5,0.28,0.28,0.44,0.28,0.25,0.5,0.28,0.28,0.25,0.5,0.33,0.25,0.56,0.44,0.5,0.44,0.33,0.5,0.78,0.28,0.44,0.25,0.39,0.44,0.33,0.5,0.44,0.5,0.39,0.25,0.33,0.56,0.72,0.25,0.33,0.25" y="688.7" x="70.9,74.3,79.3,84.3,88.7,93.7,96.4,100.4,102.9,107.9,111.2,113.8,116.5,121.5,126.0,128.5,133.0,136.9,140.8,145.3,150.3,153.0,155.8,160.3,163.0,165.5,170.6,173.3,176.1,178.6,183.6,186.9,189.4,195.0,199.5,204.5,208.9,212.3,217.3,225.0,227.7,232.2,234.8,238.7,243.1,246.4,251.5,255.9,260.9,264.8,267.4,270.7,276.2,283.5,285.9,289.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">rodents of the essential oil of Peperomia serpens (Sw.) </text>
  <text svgx:width="0.61,0.5,0.5,0.5,0.25,0.25,0.39,0.25,0.61,0.28,0.5,0.5,0.5,0.5,0.5,0.44,0.33,0.78,0.44,0.44,0.5,0.28,0.25" y="700.2" x="70.9,77.0,82.0,87.1,92.0,94.5,97.1,100.9,103.4,109.5,112.3,117.3,122.3,127.3,132.3,137.4,141.8,145.2,152.8,157.3,161.7,166.7,169.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Loud. J Ethnopharmacol.</text>
  <text svgx:width="0.5,0.5,0.5,0.5,0.28,0.5,0.5,0.5,0.28,0.5,0.5,0.5,0.33,0.5,0.5,0.25,0.25" y="700.2" x="174.5,179.5,184.5,189.5,194.5,197.3,202.2,207.3,212.3,215.0,220.1,225.0,230.0,233.4,238.4,243.4,245.9" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2011;138:479-86. </text>
  <text svgx:width="0.67,0.44,0.28,0.44,0.5,0.44,0.5,0.39,0.44,0.25,0.72,0.25,0.25,0.72,0.28,0.78,0.25,0.89,0.89,0.25,0.25,0.89,0.44,0.5,0.5,0.28,0.39,0.25,0.61,0.25,0.25,0.72,0.28,0.78,0.25,0.56,0.72,0.25,0.25,0.33,0.5,0.5,0.28,0.5,0.28,0.28,0.28,0.5,0.5,0.25" y="94.3" x="306.1,312.8,317.2,320.1,324.5,329.5,333.9,339.0,342.9,347.3,349.5,356.8,359.3,361.5,368.7,371.5,379.2,381.5,390.4,399.3,401.8,404.1,413.0,417.5,422.5,427.5,430.3,434.2,436.5,442.6,445.1,447.3,454.5,457.3,465.0,467.3,472.9,480.1,482.6,484.9,488.2,493.2,498.2,501.0,506.0,508.8,511.6,514.4,519.4,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Rajapakse N, Kim MM, Mendis E, Kim SK. Inhibition </text>
  <text svgx:width="0.5,0.33,0.25,0.28,0.5,0.5,0.5,0.44,0.28,0.5,0.28,0.44,0.25,0.5,0.28,0.28,0.33,0.28,0.44,0.25,0.5,0.5,0.28,0.5,0.44,0.25,0.39,0.5,0.5,0.28,0.5,0.44,0.39,0.44,0.25,0.44,0.5,0.5,0.25,0.44,0.5,0.44,0.28,0.5,0.5,0.5,0.5,0.5,0.44,0.5,0.44,0.39,0.44,0.33" y="105.7" x="306.1,311.1,314.5,316.7,319.4,324.5,329.4,334.5,338.9,341.7,346.7,349.5,353.9,356.1,361.1,363.9,366.6,370.0,372.8,377.2,379.4,384.4,389.4,392.2,397.2,401.7,403.9,407.8,412.8,417.8,420.5,425.5,430.0,433.9,438.3,440.5,445.0,450.0,455.0,457.2,461.7,466.7,471.1,473.9,478.9,483.9,488.9,493.9,498.9,503.3,508.3,512.8,516.7,521.1" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">of inducible nitric oxide synthase and cyclooxygenase-</text>
  <text svgx:width="0.5,0.25,0.28,0.5,0.25,0.28,0.28,0.5,0.5,0.5,0.5,0.28,0.5,0.39,0.44,0.44,0.44,0.5,0.44,0.33,0.28,0.5,0.44,0.33,0.39,0.28,0.28,0.78,0.5,0.28,0.44,0.28,0.44,0.5,0.25,0.67,0.72,0.94,0.5,0.5,0.5,0.25,0.5,0.25,0.44,0.44,0.28,0.28,0.39,0.25,0.5,0.5,0.25" y="117.2" x="306.1,311.2,313.3,316.1,321.1,323.3,326.1,328.8,333.8,338.9,343.8,348.9,351.6,356.6,360.5,365.0,369.4,373.8,378.9,383.3,386.6,389.3,394.4,398.8,402.1,406.0,408.8,411.5,419.2,424.2,427.0,431.5,434.2,438.7,443.7,445.8,452.5,459.8,469.2,474.2,479.2,484.2,486.7,491.7,493.9,498.3,502.8,505.6,508.3,512.2,514.4,519.4,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2 in lipopolysaccharide-stimulated RAW264.7 cells by </text>
  <text svgx:width="0.44,0.44,0.33,0.5,0.5,0.5,0.5,0.5,0.5,0.28,0.5,0.33,0.5,0.28,0.44,0.28,0.44,0.5,0.25,0.5,0.28,0.5,0.44,0.5,0.39,0.44,0.78,0.28,0.5,0.44,0.25,0.28,0.44,0.5,0.44,0.39,0.25,0.5,0.28,0.44,0.44,0.44,0.25,0.5,0.28,0.44,0.25,0.5,0.5,0.72,0.5,0.33" y="128.7" x="306.1,310.6,315.0,318.4,323.4,328.4,333.4,338.4,343.4,348.4,351.2,356.2,359.5,364.6,367.3,371.8,374.6,379.0,384.0,386.1,391.1,393.9,398.9,403.3,408.3,412.2,416.7,424.4,427.1,432.2,436.6,438.7,441.5,445.9,451.0,455.4,459.2,461.3,466.3,469.1,473.6,478.0,482.5,484.6,489.6,492.4,496.8,498.9,503.9,508.9,516.2,521.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">carboxybutyrylated glucosamine takes place via down-</text>
  <text svgx:width="0.33,0.44,0.5,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.78,0.28,0.28,0.5,0.5,0.44,0.5,0.33,0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.44,0.5,0.25,0.55,0.5,0.33,0.5,0.28,0.44,0.28,0.5,0.25,0.55,0.5,0.28,0.5,0.44,0.39,0.44,0.33" y="140.2" x="306.1,309.5,313.9,318.9,323.9,326.7,331.1,333.9,336.7,341.7,346.7,349.2,356.7,361.7,365.0,367.5,375.0,382.8,385.6,388.3,393.4,398.4,402.8,407.8,411.2,415.6,420.0,422.8,425.6,430.6,435.0,437.8,442.2,447.2,449.7,457.2,462.2,465.6,470.6,473.4,477.8,480.6,485.6,488.1,495.6,500.6,503.4,508.4,512.8,516.7,521.1" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">regulation of mitogen-activated protein kinase-</text>
  <text svgx:width="0.78,0.44,0.5,0.28,0.44,0.28,0.44,0.5,0.25,0.55,0.5,0.5,0.44,0.28,0.44,0.44,0.33,0.25,0.55,0.33,0.44,0.44,0.28,0.5,0.33,0.33,0.5,0.44,0.5,0.5,0.44,0.67,0.25,0.55,0.39,0.28,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.25,0.55,0.33,0.78,0.78,0.5,0.5,0.5,0.28,0.33" y="151.7" x="306.1,313.9,318.3,323.3,326.1,330.5,333.3,337.8,342.8,345.3,346.8,351.7,356.8,361.2,364.0,368.5,372.9,376.3,378.8,380.2,383.6,388.0,392.5,395.2,400.2,403.5,406.9,411.9,416.3,421.3,426.3,430.7,437.4,439.9,441.4,445.3,448.0,453.0,458.1,462.5,465.3,468.0,473.0,478.1,480.5,483.0,484.5,487.8,495.6,503.2,508.3,513.3,518.3,521.1" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">mediated nuclear factor-kappaB signaling. Immunol-</text>
  <text svgx:width="0.5,0.5,0.5,0.25" y="163.2" x="306.1,311.2,316.2,321.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">ogy.</text>
  <text svgx:width="0.5,0.5,0.5,0.5,0.28,0.5,0.5,0.5,0.28,0.5,0.5,0.5,0.33,0.5,0.5,0.25,0.25" y="163.2" x="326.2,331.1,336.1,341.2,346.2,348.9,353.9,358.9,364.0,366.7,371.7,376.7,381.7,385.0,390.0,395.0,397.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2008;123:348-57. </text>
  <text svgx:width="0.67,0.44,0.5,0.25,0.55,0.72,0.89,0.25,0.25,0.55,0.89,0.72,0.56,0.25,0.55,0.5,0.28,0.5,0.44,0.39,0.44,0.25,0.55,0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.78,0.44,0.44,0.33,0.5,0.5,0.5,0.44,0.5,0.44,0.39,0.25,0.25,0.55,0.39,0.25" y="184.7" x="306.1,312.8,317.2,322.2,324.8,326.5,333.8,342.6,345.1,347.6,349.4,358.3,365.5,371.1,373.6,375.3,380.4,383.1,388.2,392.6,396.5,400.9,403.4,405.2,409.7,414.2,416.9,419.7,424.7,429.1,431.9,434.6,439.7,444.7,447.2,449.0,451.7,456.8,459.3,461.1,468.8,473.2,477.7,481.0,486.0,491.0,496.1,500.4,505.5,509.9,513.8,516.3,518.8,520.6,524.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Rao KM. MAP kinase activation in macrophages. J </text>
  <text svgx:width="0.61,0.44,0.5,0.5,0.5,0.44,0.25,0.67,0.28,0.5,0.28,0.25" y="196.2" x="306.1,312.3,316.7,321.7,326.7,331.8,336.2,338.7,345.3,348.1,353.1,355.9" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Leukoc Biol.</text>
  <text svgx:width="0.5,0.5,0.5,0.5,0.28,0.5,0.5,0.28,0.5,0.33,0.5,0.5,0.25,0.25" y="196.2" x="360.8,365.8,370.9,375.8,380.9,383.6,388.6,393.6,396.4,401.4,404.7,409.7,414.7,417.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2001;69:3-10. </text>
  <text svgx:width="0.67,0.5,0.44,0.44,0.44,0.25,0.55,0.67,0.25,0.25,0.55,0.56,0.28,0.28,0.44,0.72,0.44,0.33,0.44,0.28,0.5,0.25,0.55,0.72,0.72,0.25,0.25,0.55,0.67,0.5,0.44,0.28,0.5,0.5,0.5,0.5,0.5,0.44,0.5,0.44,0.39,0.44,0.39,0.25,0.55,0.44,0.5,0.5,0.25" y="217.7" x="306.1,312.8,317.8,322.2,326.7,331.1,333.6,339.2,345.8,348.3,350.8,356.3,361.8,364.6,367.4,371.8,379.1,383.5,386.8,391.3,394.0,399.0,401.5,407.0,414.2,421.4,423.9,426.4,432.0,438.7,443.7,448.1,450.9,455.9,460.9,465.9,470.9,475.9,480.3,485.3,489.7,493.6,498.1,501.9,504.5,510.0,514.4,519.4,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Rocca B, FitzGerald GA. Cyclooxygenases and </text>
  <text svgx:width="0.5,0.33,0.5,0.39,0.28,0.44,0.5,0.28,0.44,0.5,0.5,0.28,0.5,0.39,0.28,0.25,0.55,0.39,0.5,0.44,0.5,0.28,0.5,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.28,0.78,0.78,0.5,0.5,0.44,0.25,0.55,0.33,0.44,0.39,0.5,0.5,0.5,0.39,0.44,0.25,0.25,0.55,0.33,0.5,0.28,0.25" y="229.2" x="306.1,311.1,314.4,319.5,323.4,326.2,330.6,335.6,338.4,342.8,347.8,352.8,355.5,360.6,364.5,367.2,369.7,370.9,374.9,379.9,384.3,389.3,392.0,397.1,402.0,404.5,405.8,410.8,415.8,418.3,419.5,422.3,427.3,431.8,434.3,435.5,438.3,446.0,453.7,458.7,463.8,468.2,470.7,472.0,475.4,479.8,483.8,488.7,493.8,498.8,502.6,507.1,509.6,512.1,513.3,516.6,521.7,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">prostaglandins: shaping up the immune response. Int </text>
  <text svgx:width="0.33,0.78,0.78,0.5,0.5,0.5,0.5,0.5,0.44,0.33,0.78,0.44,0.44,0.5,0.28,0.25" y="240.7" x="306.1,309.5,317.2,324.9,329.9,335.0,340.0,345.0,350.0,354.5,357.8,365.6,370.0,374.5,379.5,382.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Immunopharmacol.</text>
  <text svgx:width="0.5,0.5,0.5,0.5,0.28,0.5,0.28,0.5,0.5,0.5,0.33,0.5,0.5,0.25,0.25" y="240.7" x="387.2,392.3,397.3,402.2,407.3,410.0,415.1,417.8,422.8,427.8,432.8,436.1,441.1,446.1,448.6" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2002;2:603-30. </text>
  <text svgx:width="0.67,0.5,0.33,0.28,0.5,0.5,0.25,0.55,0.72,0.61,0.25,0.25,0.55,0.67,0.28,0.5,0.44,0.28,0.33,0.5,0.25,0.55,0.89,0.25,0.25,0.55,0.39,0.5,0.5,0.44,0.39,0.25,0.55,0.56,0.25,0.25,0.55,0.56,0.44,0.28,0.5,0.5,0.44,0.28,0.33,0.5,0.25,0.55,0.61,0.25,0.25,0.55,0.61,0.5,0.5,0.44,0.39,0.25" y="262.2" x="306.1,312.8,317.8,321.2,323.9,328.9,334.0,336.5,337.9,345.1,351.2,353.7,356.2,357.7,364.3,367.1,372.1,376.6,379.3,382.6,387.7,390.2,391.6,400.5,403.0,405.5,407.0,410.8,415.8,420.8,425.2,429.1,431.6,433.1,438.7,441.2,443.7,445.1,450.7,455.2,457.9,462.9,467.9,472.4,475.1,478.5,483.5,486.0,487.4,493.6,496.1,498.6,500.0,506.1,511.1,516.1,520.5,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Rufino AT, Ribeiro M, Judas F, Salgueiro L, Lopes </text>
  <text svgx:width="0.89,0.67,0.25,0.25,0.55,0.67,0.44,0.5,0.44,0.28,0.44,0.28,0.33,0.5,0.25,0.55,0.67,0.25,0.25,0.55,0.44,0.28,0.25,0.55,0.44,0.28,0.25,0.25,0.55,0.72,0.5,0.28,0.28,0.33,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25,0.55,0.44,0.5,0.5,0.25" y="273.7" x="306.1,315.0,321.7,324.2,326.7,331.7,338.4,342.8,347.9,352.3,355.1,359.5,362.3,365.6,370.6,373.1,378.2,384.9,387.4,389.9,394.9,399.4,402.1,404.6,409.7,414.1,416.8,419.3,421.8,426.8,434.0,439.1,441.9,444.6,448.0,450.7,455.7,459.0,461.8,466.3,474.0,481.7,486.2,489.0,494.0,497.4,502.4,504.9,509.9,514.4,519.4,524.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">MC, Cavaleiro C, et al. Anti-inflammatory and </text>
  <text svgx:width="0.44,0.5,0.5,0.5,0.5,0.33,0.5,0.5,0.33,0.5,0.28,0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.55,0.44,0.44,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.33,0.56,0.33,0.33,0.44,0.28,0.5,0.5,0.44,0.33,0.5,0.28,0.5,0.44,0.5,0.44,0.28,0.25" y="285.2" x="306.1,310.5,315.6,320.6,325.6,330.6,333.9,338.9,343.9,347.2,352.3,355.0,359.5,363.9,366.7,369.4,374.5,378.9,381.4,391.3,395.7,400.2,402.9,405.7,410.7,413.5,416.3,421.2,423.8,433.7,438.7,442.0,444.5,454.4,457.7,463.3,466.7,470.0,474.4,477.1,482.1,487.1,491.6,494.9,499.9,502.7,507.7,512.1,517.2,521.6,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">chondroprotective activity of (+)-alpha-pinene: </text>
  <text svgx:width="0.39,0.28,0.33,0.5,0.44,0.28,0.5,0.33,0.44,0.28,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.44,0.5,0.44,0.5,0.28,0.28,0.5,0.78,0.44,0.33,0.28,0.44,0.25,0.55,0.39,0.44,0.28,0.44,0.44,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.25,0.55,0.39,0.25,0.55,0.72,0.44,0.28,0.25,0.55,0.56,0.33,0.5,0.5,0.25" y="296.7" x="306.1,310.0,312.8,316.1,321.1,325.6,328.3,333.3,336.6,341.1,343.9,346.4,349.0,353.4,358.4,363.4,365.9,368.5,373.0,378.0,382.4,387.5,390.2,393.0,398.0,405.7,410.2,413.5,416.3,420.8,423.3,425.9,429.7,434.2,436.9,441.4,445.8,448.6,451.3,456.4,459.2,461.9,466.9,469.4,471.9,474.5,478.4,480.9,483.5,490.7,495.1,497.9,500.4,503.0,508.6,511.9,516.9,521.9" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">structural and enantiomeric selectivity. J Nat Prod.</text>
  <text svgx:width="0.5,0.5,0.5,0.5,0.28,0.5,0.5,0.28,0.5,0.5,0.5,0.33,0.5,0.25,0.25" y="308.2" x="306.1,311.2,316.1,321.1,326.2,328.9,333.9,338.9,341.7,346.7,351.7,356.7,360.0,365.0,367.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2014;77:264-9. </text>
  <text svgx:width="0.67,0.5,0.33,0.28,0.5,0.5,0.25,0.72,0.61,0.25,0.25,0.67,0.28,0.5,0.44,0.28,0.33,0.5,0.25,0.89,0.25,0.25,0.56,0.5,0.5,0.39,0.44,0.25,0.67,0.25,0.25,0.39,0.5,0.5,0.44,0.39,0.25,0.56,0.25,0.25,0.56,0.44,0.28,0.5,0.5,0.44,0.28,0.33,0.5,0.25,0.61,0.25,0.25" y="329.7" x="306.1,312.8,317.8,321.2,323.9,328.9,333.9,336.5,343.7,349.8,352.3,354.9,361.6,364.3,369.3,373.8,376.5,379.8,384.9,387.4,396.3,398.8,401.4,406.9,411.9,416.9,420.9,425.2,427.8,434.5,437.0,439.6,443.4,448.4,453.4,457.9,461.8,464.4,469.9,472.4,475.0,480.5,484.9,487.7,492.7,497.8,502.2,505.0,508.3,513.3,515.8,522.0,524.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Rufino AT, Ribeiro M, Sousa C, Judas F, Salgueiro L, </text>
  <text svgx:width="0.67,0.44,0.5,0.44,0.28,0.44,0.28,0.33,0.5,0.25,0.25,0.55,0.67,0.25,0.25,0.55,0.44,0.28,0.25,0.55,0.44,0.28,0.25,0.25,0.55,0.61,0.5,0.44,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.44,0.5,0.28,0.28,0.33" y="341.2" x="306.1,312.8,317.2,322.2,326.7,329.4,333.9,336.6,339.9,345.0,347.4,349.9,357.3,363.9,366.4,368.9,376.3,380.7,383.4,385.9,393.3,397.7,400.5,402.9,405.5,412.8,418.9,423.9,428.3,431.1,436.1,440.5,443.3,446.1,451.1,456.1,458.6,465.9,470.9,474.2,476.7,484.0,486.7,491.8,496.2,498.7,506.0,510.5,515.5,518.3,521.0" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Cavaleiro, C, et al. Evaluation of the anti-</text>
  <text svgx:width="0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25,0.25,0.55,0.44,0.5,0.28,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.5,0.28,0.28,0.44,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.33,0.5,0.33,0.44,0.5,0.44,0.5,0.5,0.28,0.28,0.44,0.25,0.55,0.44,0.33,0.33,0.44,0.44,0.28,0.39,0.25" y="352.7" x="306.1,308.9,313.9,317.3,320.0,324.5,332.2,340.0,344.5,347.2,352.3,355.6,360.6,363.1,365.6,366.9,371.3,376.3,379.1,381.9,385.2,389.6,394.1,396.8,401.3,406.3,411.3,414.1,416.9,421.3,423.8,425.1,429.5,434.6,439.6,442.1,443.4,448.4,451.7,456.7,460.1,464.5,469.6,474.0,479.0,484.0,486.7,489.5,493.9,496.4,497.8,502.2,505.5,508.9,513.3,517.8,520.5,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">inflammatory, anti-catabolic and pro-anabolic effects </text>
  <text svgx:width="0.5,0.33,0.25,0.55,0.61,0.33,0.44,0.44,0.33,0.5,0.5,0.5,0.5,0.5,0.28,0.28,0.44,0.5,0.44,0.25,0.25,0.55,0.78,0.5,0.33,0.44,0.44,0.5,0.44,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.28,0.28,0.78,0.5,0.5,0.44,0.5,0.44,0.25,0.55,0.28,0.5,0.25,0.55,0.44,0.25,0.55,0.44,0.44,0.28,0.28,0.25" y="364.2" x="306.1,311.1,314.5,317.0,318.6,324.6,328.0,332.5,336.9,340.3,345.2,350.2,355.2,360.3,365.2,367.9,370.7,375.1,380.2,384.6,387.2,389.7,391.2,399.0,404.0,407.3,411.8,416.2,421.3,425.6,428.1,429.7,434.2,439.2,444.2,446.7,448.3,451.1,453.8,461.5,466.5,471.6,476.0,481.1,485.4,487.9,489.5,492.3,497.3,499.8,501.4,505.9,508.4,509.9,514.4,518.9,521.7,524.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">of E-caryophyllene, myrcene and limonene in a cell </text>
  <text svgx:width="0.78,0.5,0.5,0.44,0.28,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.39,0.28,0.44,0.5,0.44,0.33,0.28,0.5,0.33,0.28,0.28,0.28,0.39,0.25,0.25,0.55,0.61,0.5,0.33,0.25,0.55,0.39,0.25,0.55,0.56,0.5,0.44,0.33,0.78,0.44,0.44,0.5,0.28,0.25" y="375.7" x="306.1,313.8,318.8,323.9,328.3,331.1,333.6,335.5,340.5,343.8,346.3,348.2,353.2,357.1,359.8,364.3,369.3,373.8,377.1,379.8,384.8,388.2,391.0,393.7,396.5,400.4,402.9,405.4,407.3,413.4,418.4,421.7,424.2,426.1,430.0,432.5,434.3,439.8,444.9,449.3,452.6,460.3,464.8,469.2,474.2,477.0" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">model of osteoarthritis. Eur J Pharmacol.</text>
  <text svgx:width="0.5,0.5,0.5,0.5,0.28,0.5,0.5,0.5,0.28,0.25" y="375.7" x="483.8,488.8,493.8,498.8,503.9,506.6,511.6,516.6,521.6,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2015;750: </text>
  <text svgx:width="0.5,0.5,0.5,0.33,0.5,0.5,0.25,0.25" y="387.2" x="306.1,311.2,316.1,321.1,324.5,329.4,334.5,337.0" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">141-50. </text>
  <text svgx:width="0.56,0.5,0.5,0.25,0.55,0.67,0.72,0.25,0.25,0.55,0.67,0.5,0.5,0.5,0.5,0.25,0.55,0.72,0.72,0.25,0.25,0.55,0.89,0.5,0.5,0.5,0.5,0.5,0.33,0.44,0.5,0.5,0.28,0.44,0.25,0.55,0.39,0.28,0.5,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.5,0.44,0.25" y="408.7" x="306.1,311.7,316.7,321.7,324.2,327.6,334.3,341.6,344.1,346.6,350.0,356.6,361.6,366.6,371.6,376.7,379.2,382.5,389.8,397.0,399.5,402.0,405.4,414.3,419.3,424.3,429.4,434.3,439.3,442.7,447.1,452.1,457.2,459.9,464.4,466.9,470.3,474.2,476.9,481.9,487.0,492.0,494.5,497.9,502.9,506.3,508.8,512.2,514.9,520.0,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Sun BY, Chung YH. Monbographic study of the </text>
  <text svgx:width="0.61,0.44,0.5,0.33,0.44,0.44,0.44,0.44,0.25,0.28,0.5,0.25,0.72,0.5,0.33,0.44,0.44,0.25,0.25,0.72,0.5,0.33,0.44,0.44,0.5,0.25,0.39,0.25,0.56,0.28,0.44,0.5,0.28,0.25,0.61,0.44,0.5,0.25" y="420.2" x="306.1,312.2,316.7,321.7,325.1,329.5,334.0,338.3,342.8,345.9,348.6,353.6,356.6,363.8,368.8,372.2,376.6,381.0,383.5,386.5,393.8,398.8,402.1,406.6,411.0,416.0,419.0,422.8,425.9,431.5,434.3,438.7,443.7,446.4,449.5,455.6,460.0,465.0" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Lauracea in Korea. Korean J Plant Tax.</text>
  <text svgx:width="0.5,0.5,0.5,0.5,0.28,0.5,0.5,0.28,0.5,0.5,0.5,0.33" y="420.2" x="470.5,475.5,480.5,485.5,490.6,493.3,498.3,503.3,506.0,511.1,516.1,521.0" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">1988;18:133-</text>
  <text svgx:width="0.5,0.5,0.25,0.25" y="431.7" x="306.1,311.2,316.1,318.6" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">51. </text>
  <text svgx:width="0.56,0.5,0.33,0.5,0.25,0.72,0.39,0.25,0.25,0.67,0.5,0.5,0.5,0.25,0.72,0.56,0.25,0.25,0.67,0.5,0.44,0.25,0.72,0.72,0.25,0.25,0.72,0.44,0.5,0.25,0.56,0.56,0.25,0.25,0.72,0.44,0.5,0.78,0.25,0.72,0.56,0.25,0.25,0.56,0.44,0.33,0.5,0.25" y="453.2" x="306.1,311.7,316.7,320.0,325.1,327.8,335.0,338.9,341.4,344.1,350.8,355.8,360.8,365.8,368.5,375.8,381.3,383.8,386.5,393.2,398.2,402.7,405.4,412.6,419.9,422.4,425.1,432.3,436.8,441.8,444.5,450.1,455.6,458.1,460.8,468.1,472.5,477.6,485.2,488.0,495.3,500.8,503.3,506.0,511.6,516.0,519.4,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Surh YJ, Chun KS, Cha HH, Han SS, Keum YS, Park </text>
  <text svgx:width="0.72,0.72,0.25,0.25,0.55,0.44,0.28,0.25,0.55,0.44,0.28,0.25,0.25,0.55,0.89,0.5,0.28,0.44,0.44,0.5,0.28,0.44,0.33,0.25,0.55,0.78,0.44,0.44,0.5,0.44,0.5,0.28,0.39,0.78,0.39,0.25,0.55,0.5,0.5,0.5,0.44,0.33,0.28,0.5,0.28,0.5,0.5,0.25" y="464.7" x="306.1,313.4,320.6,323.1,325.6,333.2,337.7,340.4,342.9,350.5,355.0,357.7,360.3,362.8,370.4,379.3,384.3,387.1,391.5,395.9,401.0,403.7,408.2,411.5,414.0,421.6,429.4,433.8,438.3,443.3,447.7,452.8,455.5,459.4,467.1,471.0,473.5,481.2,486.2,491.2,496.2,500.6,503.9,506.7,511.7,514.5,519.5,524.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">KK, et al. Molecular mechanisms underlying </text>
  <text svgx:width="0.44,0.5,0.44,0.78,0.5,0.5,0.33,0.44,0.5,0.44,0.5,0.28,0.28,0.5,0.44,0.25,0.55,0.44,0.44,0.28,0.28,0.5,0.28,0.28,0.28,0.44,0.39,0.25,0.55,0.5,0.33,0.25,0.55,0.44,0.5,0.28,0.28,0.33,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25" y="476.2" x="306.1,310.5,315.6,320.0,327.7,332.7,337.8,341.1,345.6,350.6,355.0,360.1,362.8,365.5,370.6,375.0,377.5,385.8,390.2,394.6,397.4,400.1,405.2,408.0,410.7,413.5,417.9,421.8,424.3,432.5,437.6,440.9,443.4,451.7,456.1,461.1,463.9,466.7,470.0,472.7,477.7,481.0,483.8,488.3,496.1,503.9,508.3,511.1,516.1,519.4,524.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">chemopreventive activities of anti-inflammatory </text>
  <text svgx:width="0.5,0.5,0.5,0.28,0.5,0.44,0.5,0.44,0.78,0.28,0.44,0.44,0.28,0.39,0.28,0.25,0.5,0.5,0.72,0.5,0.33,0.33,0.44,0.5,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.67,0.72,0.72,0.33,0.5,0.25,0.44,0.5,0.5,0.25,0.28,0.72,0.72,0.56,0.25" y="487.7" x="306.1,311.1,316.2,321.2,323.9,329.0,333.3,338.4,342.8,350.5,353.3,357.8,362.2,365.0,368.9,371.7,374.0,379.1,384.1,391.3,396.3,399.6,402.9,407.4,412.4,417.4,420.2,424.6,427.3,430.1,435.1,440.1,442.4,447.5,450.8,453.1,459.7,466.9,474.2,477.5,482.5,484.8,489.3,494.3,499.3,501.6,504.4,511.6,518.8,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">phytochemicals: down-regulation of COX-2 and iNOS </text>
  <text svgx:width="0.28,0.5,0.33,0.5,0.5,0.5,0.5,0.25,0.39,0.5,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.72,0.56,0.33,0.5,0.44,0.5,0.5,0.44,0.25,0.67,0.25,0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.25,0.89,0.5,0.28,0.44,0.28,0.25" y="499.2" x="306.1,308.9,313.9,317.2,322.3,327.3,332.3,337.3,340.5,344.4,349.4,354.3,359.4,362.7,367.1,371.0,374.9,377.7,382.7,387.7,390.9,395.9,399.3,402.4,409.6,415.1,418.5,423.5,427.9,433.0,438.0,442.5,445.6,452.3,455.5,459.9,464.3,467.1,469.9,474.9,479.3,482.1,484.8,489.9,494.8,497.3,500.5,509.4,514.4,517.2,521.6,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">through suppression of NF-kappa B activation. Mutat </text>
  <text svgx:width="0.67,0.44,0.39,0.25" y="510.7" x="306.1,312.8,317.2,321.1" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Res.</text>
  <text svgx:width="0.5,0.5,0.5,0.5,0.28,0.5,0.5,0.5,0.33,0.5,0.5,0.5,0.28,0.5,0.5,0.5,0.33,0.5,0.5,0.25,0.25" y="510.7" x="326.2,331.1,336.1,341.2,346.2,348.9,353.9,358.9,363.9,367.2,372.2,377.2,382.3,385.0,390.0,395.0,400.0,403.3,408.3,413.3,415.8" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2001;480-481:243-68. </text>
  <text svgx:width="0.61,0.5,0.78,0.44,0.5,0.25,0.33,0.25,0.25,0.72,0.44,0.33,0.28,0.44,0.5,0.5,0.28,0.5,0.25,0.72,0.25,0.25,0.72,0.28,0.28,0.28,0.44,0.25,0.72,0.25,0.25,0.72,0.5,0.5,0.78,0.44,0.44,0.25,0.33,0.61,0.25,0.25,0.56,0.28,0.5,0.33,0.28,0.5,0.44,0.5,0.44,0.25" y="532.2" x="306.1,312.2,317.3,325.0,329.4,334.4,337.0,340.4,342.9,345.4,352.6,357.1,360.4,363.1,367.6,372.6,377.6,380.3,385.4,387.9,395.1,397.6,400.2,407.4,410.2,413.0,415.7,420.2,422.8,430.0,432.5,435.0,442.3,447.3,452.3,460.0,464.5,468.9,471.5,474.8,481.0,483.5,486.0,491.6,494.4,499.4,502.8,505.5,510.5,515.0,520.0,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Tumen I, Hafizoglu H, Kilic A, Donmez IE, Sivrikaya </text>
  <text svgx:width="0.72,0.25,0.25,0.67,0.44,0.5,0.5,0.44,0.5,0.44,0.5,0.25,0.89,0.25,0.25,0.72,0.28,0.44,0.28,0.5,0.39,0.25,0.44,0.5,0.5,0.25,0.44,0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.44,0.5,0.28,0.39,0.25,0.5,0.33,0.25,0.44,0.39,0.39,0.44,0.5,0.28,0.28,0.44,0.28,0.25,0.5,0.28,0.28,0.25" y="543.7" x="306.1,313.3,315.8,317.8,324.5,328.9,333.9,338.9,343.4,348.4,352.8,357.8,359.8,368.6,371.1,373.1,380.3,383.1,387.5,390.2,395.3,399.2,401.2,405.6,410.6,415.6,417.5,422.0,427.0,432.0,435.9,438.6,441.4,444.2,449.2,453.7,458.7,461.5,465.3,467.3,472.3,475.6,477.5,481.9,485.8,489.7,494.1,499.2,501.9,504.7,509.1,511.9,513.9,518.9,521.7,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">H, Reunanen M. Yields and constituents of essential oil </text>
  <text svgx:width="0.33,0.33,0.5,0.78,0.25,0.44,0.5,0.5,0.44,0.39,0.25,0.5,0.33,0.25,0.56,0.28,0.5,0.44,0.44,0.44,0.44,0.44,0.25,0.39,0.5,0.5,0.25,0.25,0.5,0.44,0.28,0.28,0.5,0.44,0.28,0.5,0.25,0.5,0.33,0.5,0.72,0.5,0.25,0.28,0.5,0.25,0.61,0.5,0.33,0.5,0.44,0.5,0.25,0.25" y="555.2" x="306.1,309.5,312.8,317.8,325.5,327.9,332.3,337.4,342.4,346.8,350.7,353.0,358.0,361.4,363.7,369.3,372.1,377.1,381.5,386.0,390.4,394.9,399.3,401.7,405.6,410.6,415.6,418.0,420.4,425.4,429.8,432.6,435.4,440.4,444.8,447.6,452.6,454.9,459.9,463.2,468.2,475.5,480.5,482.9,485.6,490.6,493.0,499.1,504.1,507.5,512.5,516.9,521.9,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">from cones of Pinaceae spp. natively grown in Turkey. </text>
  <text svgx:width="0.89,0.5,0.28,0.44,0.44,0.5,0.28,0.44,0.39,0.25" y="566.7" x="306.1,315.0,320.0,322.8,327.3,331.7,336.7,339.5,343.9,347.8" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Molecules.</text>
  <text svgx:width="0.5,0.5,0.5,0.5,0.28,0.5,0.5,0.28,0.5,0.5,0.5,0.5,0.33,0.5,0.5,0.5,0.25,0.25" y="566.7" x="352.8,357.8,362.8,367.8,372.8,375.5,380.6,385.6,388.3,393.4,398.3,403.3,408.4,411.7,416.6,421.6,426.6,429.1" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2010;15:5797-806. </text>
  <text svgx:width="0.72,0.28,0.5,0.25,0.55,0.61,0.25,0.25,0.55,0.56,0.5,0.28,0.28,0.28,0.25,0.55,0.89,0.25,0.25,0.55,0.72,0.5,0.5,0.25,0.55,0.72,0.72,0.25,0.25,0.55,0.5,0.33,0.33,0.89,0.44,0.28,0.5,0.5,0.28,0.39,0.5,0.28,0.33,0.28,0.5,0.5,0.28,0.33,0.5,0.44,0.5,0.5,0.28,0.25" y="588.2" x="306.1,313.4,316.1,321.2,323.7,326.8,332.9,335.4,337.9,340.9,346.5,351.5,354.3,357.1,359.9,362.4,365.4,374.3,376.8,379.3,382.4,389.7,394.6,399.7,402.2,405.3,412.5,419.7,422.2,424.7,427.8,432.8,436.1,439.5,448.3,452.8,455.6,460.6,465.6,468.3,472.2,477.3,480.0,483.3,486.1,491.1,496.1,498.9,502.2,507.3,511.6,516.7,521.7,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Uto T, Fujii M, Hou DX. 6-(Methylsulfinyl)hexyl </text>
  <text svgx:width="0.28,0.39,0.5,0.28,0.5,0.28,0.5,0.44,0.5,0.44,0.5,0.44,0.28,0.44,0.25,0.55,0.39,0.5,0.5,0.5,0.33,0.44,0.39,0.39,0.44,0.39,0.25,0.55,0.28,0.5,0.5,0.5,0.44,0.28,0.5,0.28,0.44,0.25,0.55,0.5,0.28,0.28,0.33,0.28,0.44,0.25,0.55,0.5,0.5,0.28,0.5,0.44,0.25" y="599.7" x="306.1,308.9,312.8,317.8,320.6,325.6,328.4,333.4,337.8,342.8,347.2,352.2,356.7,359.4,363.9,366.4,373.2,377.1,382.1,387.1,392.1,395.4,399.9,403.8,407.7,412.2,416.1,418.6,425.3,428.1,433.1,438.1,443.2,447.6,450.4,455.4,458.2,462.6,465.1,471.9,476.9,479.7,482.4,485.8,488.5,493.0,495.5,502.3,507.3,512.3,515.1,520.1,524.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">isothiocyanate suppresses inducible nitric oxide </text>
  <text svgx:width="0.39,0.5,0.5,0.28,0.5,0.44,0.39,0.44,0.25,0.55,0.44,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.33,0.5,0.5,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.28,0.5,0.5,0.28,0.5,0.28,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.39,0.44,0.5,0.5,0.39,0.25" y="611.2" x="306.1,310.0,315.0,320.0,322.8,327.8,332.3,336.1,340.6,343.1,345.3,349.7,354.7,359.8,363.1,367.5,371.4,375.3,378.0,383.1,388.1,390.6,392.8,395.6,400.6,403.9,408.9,413.8,418.9,423.9,426.4,428.5,431.3,436.3,440.8,443.3,445.5,448.3,453.3,458.3,461.1,466.1,468.9,471.6,474.4,479.4,484.4,486.9,489.1,494.1,497.4,499.9,502.2,506.0,510.5,515.5,520.5,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">synthase expression through the inhibition of Janus </text>
  <text svgx:width="0.5,0.28,0.5,0.44,0.39,0.44,0.25,0.55,0.5,0.33,0.78,0.44,0.5,0.28,0.44,0.28,0.44,0.5,0.25,0.55,0.39,0.72,0.72,0.25,0.55,0.5,0.44,0.28,0.5,0.72,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.28,0.5,0.5,0.5,0.5,0.28,0.5,0.33" y="622.7" x="306.1,311.1,313.9,318.9,323.4,327.3,331.7,334.2,341.9,346.9,350.3,358.0,362.4,367.4,370.2,374.7,377.4,381.9,386.9,389.4,397.2,401.0,408.3,415.5,418.0,425.7,430.7,435.2,437.9,442.9,450.2,454.6,459.6,462.1,469.9,472.6,477.5,480.0,487.8,490.6,493.3,498.3,503.3,508.3,513.3,516.1,521.1" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">kinase 2-mediated JNK pathway in lipopoly-</text>
  <text svgx:width="0.39,0.44,0.44,0.44,0.5,0.44,0.33,0.28,0.5,0.44,0.33,0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.44,0.5,0.25,0.55,0.78,0.5,0.33,0.28,0.5,0.44,0.25,0.55,0.78,0.44,0.44,0.33,0.5,0.5,0.5,0.44,0.5,0.44,0.39,0.25,0.25,0.55,0.67,0.28,0.5,0.44,0.5,0.44,0.78,0.25" y="634.2" x="306.1,310.0,314.5,318.9,323.4,328.4,332.8,336.2,338.9,343.9,348.4,351.7,356.1,360.6,363.4,366.1,371.1,375.6,378.3,382.8,387.8,390.3,393.5,401.2,406.2,409.6,412.3,417.4,421.7,424.2,427.3,435.1,439.6,444.0,447.3,452.3,457.3,462.4,466.7,471.7,476.2,480.1,482.6,485.1,488.2,494.9,497.7,502.7,507.1,512.1,516.6,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">saccharide-activated murine macrophages. Biochem </text>
  <text svgx:width="0.56,0.5,0.44,0.33,0.78,0.44,0.44,0.5,0.28,0.25" y="645.7" x="306.1,311.7,316.7,321.1,324.4,332.1,336.6,341.0,346.0,348.8" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Pharmacol.</text>
  <text svgx:width="0.5,0.5,0.5,0.5,0.28,0.5,0.5,0.28,0.5,0.5,0.5,0.5,0.33,0.5,0.5,0.25,0.25" y="645.7" x="353.9,358.9,363.9,368.9,374.0,376.7,381.7,386.8,389.5,394.5,399.5,404.5,409.5,412.8,417.8,422.8,425.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2005;70:1211-21. </text>
  <text svgx:width="0.94,0.44,0.28,0.39,0.5,0.25,0.55,0.72,0.67,0.25,0.25,0.55,0.67,0.33,0.5,0.28,0.28,0.28,0.25,0.55,0.61,0.72,0.25,0.25,0.55,0.72,0.5,0.28,0.5,0.33,0.28,0.5,0.5,0.25,0.55,0.56,0.67,0.25,0.25,0.55,0.72,0.33,0.44,0.5,0.44,0.28,0.28,0.44,0.39,0.44,0.25,0.55,0.61,0.89,0.25,0.25" y="667.2" x="306.1,315.6,320.0,322.8,326.7,331.7,334.2,335.4,342.6,349.3,351.8,354.3,355.5,362.2,365.5,370.6,373.3,376.1,378.9,381.4,382.6,388.7,396.0,398.5,401.0,402.1,409.4,414.4,417.1,422.1,425.5,428.2,433.3,438.3,440.8,442.0,447.6,454.3,456.8,459.3,460.4,467.7,471.0,475.4,480.5,484.9,487.7,490.5,494.9,498.8,503.3,505.8,507.0,513.1,522.0,524.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Walsh NC, Crotti TN, Goldring SR, Gravallese EM. </text>
  <text svgx:width="0.67,0.5,0.44,0.5,0.78,0.44,0.28,0.28,0.44,0.25,0.55,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.39,0.28,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.44,0.33,0.33,0.44,0.44,0.28,0.39,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.5,0.25" y="678.7" x="306.1,312.8,317.8,322.3,327.3,334.9,339.4,342.2,344.9,349.4,351.9,354.1,359.1,361.9,365.8,370.3,374.7,378.6,383.0,386.9,389.7,392.2,394.5,397.2,402.2,406.7,409.2,411.4,415.8,419.1,422.5,426.9,431.3,434.1,438.0,440.5,442.7,447.7,451.1,453.6,455.8,458.6,463.6,466.9,469.7,474.1,481.9,489.7,494.2,497.0,499.7,504.7,509.7,512.2,514.5,519.5,524.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Rheumatic diseases: the effects of inflammation on </text>
  <text svgx:width="0.5,0.5,0.5,0.44,0.25,0.25,0.33,0.78,0.78,0.5,0.5,0.5,0.28,0.25,0.67,0.44,0.5,0.25" y="690.2" x="306.1,311.2,316.1,321.2,325.6,328.1,330.6,334.0,341.7,349.4,354.4,359.5,364.5,367.2,369.7,376.4,380.8,385.9" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">bone. Immunol Rev.</text>
  <text svgx:width="0.5,0.5,0.5,0.5,0.28,0.5,0.5,0.5,0.28,0.5,0.5,0.5,0.33,0.5,0.5,0.25,0.25" y="690.2" x="390.8,395.8,400.8,405.8,410.9,413.6,418.6,423.6,428.6,431.3,436.4,441.4,446.4,449.7,454.7,459.7,462.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2005;208:228-51. </text>
  <text svgx:width="0.94,0.44,0.5,0.5,0.25,0.56,0.72,0.25,0.25,0.61,0.44,0.5,0.25,0.72,0.72,0.25,0.25,0.72,0.28,0.44,0.5,0.25,0.39,0.72,0.25,0.25,0.72,0.44,0.5,0.5,0.25,0.39,0.67,0.25,0.25,0.72,0.44,0.5,0.25,0.72,0.61,0.25,0.25,0.67,0.5,0.44,0.5,0.5,0.25" y="711.7" x="306.1,315.6,320.1,325.0,330.1,332.1,337.6,344.8,347.4,349.4,355.5,359.9,364.9,366.9,374.2,381.4,383.9,385.9,393.1,395.9,400.4,405.4,407.4,411.3,418.5,421.0,423.0,430.2,434.7,439.7,444.7,446.7,450.6,457.2,459.8,461.7,469.0,473.5,478.4,480.4,487.7,493.8,496.3,498.4,505.0,510.0,514.4,519.4,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Wang SY, Lan XY, Xiao JH, Yang JC, Kao YT, Chang </text>
  <text svgx:width="0.56,0.61,0.25,0.25,0.72,0.5,0.28,0.28,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25,0.44,0.44,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.5,0.33,0.25,0.61,0.28,0.5,0.5,0.44,0.33,0.44,0.25,0.44,0.33,0.5,0.28,0.5,0.33,0.5,0.44,0.44,0.33,0.5,0.44,0.25" y="723.2" x="306.1,311.7,317.8,320.3,322.6,329.8,334.9,337.6,340.4,343.2,348.2,351.5,354.3,358.7,366.5,374.3,378.7,381.5,386.5,389.8,394.8,397.2,401.7,406.1,408.9,411.7,416.7,419.5,422.2,427.3,429.7,434.7,438.0,440.4,446.5,449.3,454.3,459.3,463.8,467.1,471.5,473.9,478.4,481.7,486.6,489.4,494.4,497.7,502.7,507.2,511.6,514.9,520.0,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">ST. Antiinflammatory activity of Lindera erythrocarpa </text>
  <text svgx:width="0.33,0.33,0.5,0.28,0.28,0.39,0.25,0.25,0.56,0.5,0.5,0.28,0.5,0.28,0.5,0.44,0.33,0.25,0.67,0.44,0.39,0.25" y="734.7" x="306.1,309.5,312.8,317.8,320.6,323.4,327.2,329.7,332.2,337.8,342.8,347.8,350.6,355.6,358.4,363.4,367.8,371.2,373.7,380.4,384.8,388.7" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">fruits. Phytother Res.</text>
  <text svgx:width="0.5,0.5,0.5,0.5,0.28,0.5,0.5,0.28,0.5,0.5,0.5,0.33,0.5,0.25,0.25" y="734.7" x="393.7,398.6,403.6,408.7,413.7,416.4,421.4,426.4,429.2,434.2,439.2,444.2,447.5,452.5,455.0" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2008;22:213-6. </text>
 </g>
</svg>
